Mode
Text Size
Log in / Sign up
N/A N=22 Randomized Triple-blind Treatment

The Effect of Thermotherapy on Recovery and Performance

Healthy

Enrolled (actual)
22
Serious AEs
0.0%
Results posted
Oct 2025
Primary outcome: Primary: Delayed-onset Muscle Soreness (DOMS) — 0.1; 0.1; 5; 4.1 units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Zamar Therapy CT clinic (Device)
Age
Adult · 18+ yrs
Sex
All
Sponsor
University of Applied Sciences and Arts of Southern Switzerland
Primary completion
Nov 2018

Outcome Measures

OutcomeResultp-value
PRIMARY
Delayed-onset Muscle Soreness (DOMS)
0.1; 0.1; 5; 4.1; 5.6; 5.0
PRIMARY
Ratings of Perceived Exertion (RPE)
8; 7; 14; 14; 9; 8
PRIMARY
Vertical Jump Performance (VJP)
38.51; 40.08; 31.02; 35.06; 34.59; 37.82
PRIMARY
Peak Power Output (PPO)
3,375; 3,267; 2,920; 2,963; 3,137; 3,130

Summary

This study investigates the effects of cooling on the recovery and performance characteristic in young healthy subjects. The study is divided in two projects: Project A: investigates the effects of 20 min. post-exercise cooling on vertical jump performance and delayed onset muscle soreness and rated perceived exertion. Project B: investigates the effects of 20 min. pre-exercise cooling on maximal voluntary contraction of the right M. quadriceps femoris and delayed onset muscle soreness and rated perceived exertion.

Eligibility Criteria

Inclusion Criteria

  • only healthy young subjects 18-30 years
  • no musculoskeletal surgery in trunk and lower extremities
  • injury history in trunk and lower extremity for more than one year
  • subjects taking anticonceptive medication are allowed to participate

Exclusion Criteria

  • actual injuries or injuries for less than one year in trunk and /or lower extremities
  • injury history in trunk and lower extremity for more than one year with complaints
  • anxiety of cooling
  • subjects on medication
  • pace maker
  • cardiovascular disease
  • pregnancy
  • skeletal problems
  • appendectomy for less than two years
  • Morbus Raynaud syndrome
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02506283). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search